In vitro studies as well as studies of animal models of arthritis suggest that type I IFN most likely has a protective role in RA [32, 34], although translation of the findings from the animal models to treat human RA using IFNβ therapy has thus far not been successful [34]. Here, IFNB1 is linked to rheumatoid arthritis.